Fri, February 18, 2022

Luca Issi Initiated (VERV) at Buy and Held Target at $42 on, Feb 18th, 2022

Luca Issi of RBC Capital, Initiated "Verve Therapeutics, Inc." (VERV) at Buy and Held Target at $42 on, Feb 18th, 2022.

Luca, nor any peers, have made any analyst calls on VERV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30